Roetgen, Germany

Bernd Muller

This inventor holds 1 USPTO granted patent. Top assignee: Gruenenthal Gmbh. Active years: 1985.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bernd Muller. Retrieved from https://idiyas.com/inventor/bernd-muller-gjqa4sdb

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 1985

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Bernd Muller: Innovator in Medicinal Chemistry

Introduction

Bernd Muller is a notable inventor based in Roetgen, Germany. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on specific chemical compounds.

Latest Patents

Muller holds a patent for "Cis-bicyclo[3.3.0]octane derivatives, medicaments containing them." This patent describes compounds that act as inhibitors of blood platelet aggregation and can lower blood pressure at higher doses. The compounds are characterized by their unique structural formula, where R1 can be hydrogen, a lower alkyl group, or a cation, and R2 can represent a cyclohexyl or an adamantyl group. The preparation of these compounds involves reacting specific chemical formulae, showcasing Muller's expertise in synthesizing complex medicinal compounds.

Career Highlights

Bernd Muller is associated with Gruenenthal GmbH, a company known for its focus on innovative pharmaceuticals. His work has contributed to advancements in the development of medications that address critical health issues, particularly in cardiovascular health.

Collaborations

Muller has collaborated with notable colleagues such as Horst R Boehlke and Gerriet K Loschen. These collaborations have likely enhanced the research and development processes within their projects.

Conclusion

Bernd Muller is a distinguished inventor whose work in medicinal chemistry has led to valuable innovations in the pharmaceutical industry. His contributions continue to impact the field positively, particularly in developing effective medications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…